Compare AdaptHealth Corp (AHCO) vs Lamb Weston Holdings Inc (LW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs Lamb Weston Holdings Inc — how do they compare? AdaptHealth Corp trades at $5.79 (market cap $753.09M), while Lamb Weston Holdings Inc trades at $53.19 (market cap $7.23B). The key difference: Lamb Weston Holdings Inc is far larger — about 9.6× AdaptHealth Corp's market cap, and Lamb Weston Holdings Inc pays a 2.89% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | LW | |
|---|---|---|
Market Cap | $753.09M | $7.23B |
Sector | Health | Consumer Staples |
52-Week High | $13.38 | $66.57 |
52-Week Low | $5.22 | $38.48 |
Enterprise Value | $2.77B | $11.10B |
Dividend Yield | — | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth Corp. (AHCO) trades at $5.74, up 9.96% in the last session, yet remains under pressure with a bearish technical signal and recent earnings misses. The company reported a Q2 2026 net loss of $228 million with a -6.82% margin, while selling its diabetes unit to focus on sleep and respiratory care. Valuation ratios show a low P/S of 0.23 and P/B of 0.55, but negative profitability metrics highlight operational challenges.
The outlook is mixed: analyst consensus is bullish with a $11 price target, but risks include ongoing losses, fraud investigations, and cost overruns in fixed-price contracts. Upside depends on successful business restructuring and margin improvement, while downside risks from legal and execution issues persist.
Lamb Weston (LW) trades at $53.04, up 2.37% today, near its consensus price target of $53.86. The stock shows a bullish technical trend with consistent earnings beats in recent quarters, including Q2 2026 EPS of $0.87 versus $0.626 expected. Revenue reached $6.45 billion in 2025, though net income margin declined to 4.39%. Analyst sentiment is mixed with 31.58% buy ratings, while institutional investors like Dimensional Fund Advisors increased holdings by 28.1% in Q1 2026 (SEC filing, 2026-07-29).
The outlook is cautiously optimistic given operational improvements and cost savings, but risks include international demand pressures and elevated costs. The stock offers a 3.1% dividend yield, with fiscal 2027 guidance projecting 1%-2% sales growth. Further upside depends on sustaining North American volume growth and margin stabilization amid macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Lamb Weston Holdings Inc
Lamb Weston is the world's second-largest producer of branded and private-label frozen potato products, such as French fries, sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. The company also has a small appetizer business that produces onion rings, mozzarella sticks, and cheese curds. Including joint ventures, 63% of fiscal 2022 revenue was U.S.-based, with the remainder stemming from Europe, Canada, Japan, China, Korea, Mexico, and several other countries. Lamb Weston's customer mix is estimated 58% quick-serve restaurants, 19% full-service restaurants, 8% other food services (hotels, commercial cafeterias, arenas, schools), and 16% retail. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
Read more on LW →
